Endothelin receptor antagonist bosentan improves microcirculatory blood flow in splanchnic organs in septic shock

被引:46
|
作者
Krejci, V [1 ]
Hiltebrand, LB
Erni, D
Sigurdsson, GH
机构
[1] Univ Hosp Bern, Inselspital, Dept Anesthesiol, CH-3010 Bern, Switzerland
[2] Univ Hosp Bern, Inselspital, Dept Plast & Reconstruct Surg, CH-3010 Bern, Switzerland
[3] Landspitali Univ Hosp, Dept Anesthesia & Intens Care Med, Reykjavik, Iceland
关键词
sepsis; septic shock; intestine; mucosa; muscularis; liver; kidney; pancreas; microcirculation; endothelin; bosentan; pigs;
D O I
10.1097/00003246-200301000-00031
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Objective. Splanchnic ischemia is believed to play an important role in the development of multiple organ dysfunction in septic shock. The vasoconstrictor peptide endothelin can produce an intense and sustained splanchnic vasoconstriction and is increased in sepsis. The aim of this investigation was to study the effects of an endothelin antagonist on microcirculatory blood flow in multiple abdominal organs during septic shock. Design. Prospective, controlled animal study. Setting. University-affiliated research laboratory. Subjects. Fifteen anesthetized and mechanically ventilated pigs. Interventions: Septic shock was induced by fecal peritonitis. After 120 mins of sepsis, eight animals received 10 mg/kg bosentan intravenously followed by an intravenous infusion at 5 mg.kg(-1).hr(-1) whereas seven (controls) received isotonic saline. At 240 mins after induction of sepsis both groups received hydroxyethyl starch, 20 mL/kg intravenously, to convert hypodynamic septic shock to hyperdynamic sepsis. Measurements and Main Results. Microcirculatory blood flow was measured simultaneously and continuously in the jejunal muscularis, pancreas, liver, kidney, skeletal muscle, and gastric, jejunal, and colon mucosa by using a multiple-channel laser Doppler flow meter. After 120 mins, all animals had developed signs of hypodynamic sepsis with decreased cardiac index, mean arterial blood pressure, and gastric mucosal pH. Microcirculatory blood flow in the pancreas and liver had decreased by 20% and in the jejunal muscularis by >40% (p <.01) whereas it remained virtually unchanged in the gastric, jejunal, and colonic mucosa. After 240 mins, cardiac index, mean arterial blood pressure, gastric mucosal pH, and microcirculatory blood flow in the gastric mucosa, colon mucosa, jejunal muscularis, and pancreas had all deteriorated in the controls, whereas in the bosentan-treated group, cardiac index and microcirculatory blood flow in the pancreas, gastric, and colon mucosa improved. During hyperdynamic sepsis, cardiac index increased above baseline in both groups but significantly more in the bosentan group. In the control group, microcirculatory flow returned to baseline in most tissues except in skeletal muscle and jejunal muscularis. In the bosentan group, microcirculatory flow returned to or increased above baseline in all tissues except in the muscularis of the jejunum. Conclusions., The endothelin receptor antagonist bosentan significantly improved microcirculatory blood flow in many splanchnic organs and in peripheral tissues during septic shock. The results of this study are consistent with the hypothesis that endothelin plays an important role in the regulation of microcirculatory blood flow in splanchnic as well as in peripheral tissues during, septic shock.
引用
收藏
页码:203 / 210
页数:8
相关论文
共 50 条
  • [21] Peripheral blood flow monitoring in an infant with septic shock
    Ishiguro, Akio
    Sakazaki, Sayaka
    Itakura, Ryuta
    Fujinuma, Sumie
    Oka, Shuntaro
    Motojima, Yukiko
    Sobajima, Hisanori
    Tamura, Masanori
    PEDIATRICS INTERNATIONAL, 2014, 56 (05) : 787 - 789
  • [22] Influence of severe renal dysfunction on the pharmacokinetics and metabolism of bosentan, a dual endothelin receptor antagonist
    Dingemanse, J
    van Giersbergen, PLM
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2002, 40 (07) : 310 - 316
  • [23] Bosentan, a mixed endothelin receptor antagonist, induces antidepressant-like activity in mice
    Pinho-Ribeiro, Felipe A.
    Borghi, Sergio M.
    Staurengo-Ferrari, Larissa
    Filgueiras, Guilherme B.
    Estanislau, Celio
    Verri, Waldiceu A., Jr.
    NEUROSCIENCE LETTERS, 2014, 560 : 57 - 61
  • [24] Hemodynamic effects of bosentan, an endothelin receptor antagonist, in patients with pulmonary hypertension
    Williamson, DJ
    Wallman, LL
    Jones, R
    Keogh, AM
    Scroope, F
    Penny, R
    Weber, C
    Macdonald, PS
    CIRCULATION, 2000, 102 (04) : 411 - 418
  • [25] Approaches to therapy for puhnonary hypertension: Role of the endothelin receptor antagonist bosentan
    Avdeev, S. N.
    TERAPEVTICHESKII ARKHIV, 2015, 87 (09) : 64 - 71
  • [26] Role of the endothelin receptor antagonist bosentan in the treatment of patients with pulmonary hypertension
    Tsareva, N. A.
    TERAPEVTICHESKII ARKHIV, 2013, 85 (12) : 127 - 136
  • [27] Short-term effects of terlipressin bolus infusion on sublingual microcirculatory blood flow during septic shock
    Andrea Morelli
    Abele Donati
    Christian Ertmer
    Sebastian Rehberg
    Alessandra Orecchioni
    Alessandro Di Russo
    Paolo Pelaia
    Paolo Pietropaoli
    Martin Westphal
    Intensive Care Medicine, 2011, 37 : 963 - 969
  • [28] Short-term effects of terlipressin bolus infusion on sublingual microcirculatory blood flow during septic shock
    Morelli, Andrea
    Donati, Abele
    Ertmer, Christian
    Rehberg, Sebastian
    Orecchioni, Alessandra
    Di Russo, Alessandro
    Pelaia, Paolo
    Pietropaoli, Paolo
    Westphal, Martin
    INTENSIVE CARE MEDICINE, 2011, 37 (06) : 963 - 969
  • [29] Ameliorative role of bosentan, an endothelin receptor antagonist, against sodium arsenite-induced renal dysfunction in rats
    Sharma, Ashwani Kumar
    Kaur, Japneet
    Kaur, Tajpreet
    Singh, Balbir
    Yadav, Harlokesh Narayan
    Pathak, Devendra
    Singh, Amrit Pal
    ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH, 2021, 28 (06) : 7180 - 7190
  • [30] Comparison of the protective effects of selective endothelin-a receptor antagonist, ambrisentan, and dual endothelin-A/B receptor antagonist, bosentan, in experimental renal ischemia reperfusion injury
    Kazimoglu, H.
    Uysal, E.
    Dokur, M.
    Gurer, A. O.
    Batcioglu, K.
    Uyumlu, B. A.
    Petekkaya, E.
    Karadag, M.
    BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY, 2020, 121 (08): : 547 - 553